Via Pharmaceuticals Stock Alpha and Beta Analysis
| VIAP Stock | USD 0.0005 0.00 0.000004% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Via Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Via Pharmaceuticals over a specified time horizon. Remember, high Via Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Via Pharmaceuticals' market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Via Pharmaceuticals Backtesting, Via Pharmaceuticals Valuation, Via Pharmaceuticals Correlation, Via Pharmaceuticals Hype Analysis, Via Pharmaceuticals Volatility, Via Pharmaceuticals History and analyze Via Pharmaceuticals Performance. Via Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Via Pharmaceuticals market risk premium is the additional return an investor will receive from holding Via Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Via Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Via Pharmaceuticals' performance over market.| α | 0.00 | β | 0.00 |
Via Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Via Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Via Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Via Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Via Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Via Pharmaceuticals shares will generate the highest return on investment. By understating and applying Via Pharmaceuticals stock market price indicators, traders can identify Via Pharmaceuticals position entry and exit signals to maximize returns.
Via Pharmaceuticals Return and Market Media
The median price of Via Pharmaceuticals for the period between Sat, Sep 27, 2025 and Fri, Dec 26, 2025 is 5.0E-4 with a coefficient of variation of 0.0. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Ranking ACADIA Pharmaceuticals Inc. among high performing stocks via tools - Index Update Free Growth Oriented Trading Recommendations - newser.com | 10/17/2025 |
2 | Pharma stock jumps 3 percent after FII acquires 1,12,492 shares in the company via block deal - Trade Brains | 10/24/2025 |
3 | Tarsus sets Nov. 4 webcast to share thirdquarter results at 130 p.m. PT - Stock Titan | 10/28/2025 |
4 | Will Ironwood Pharmaceuticals Inc. stock maintain dividend yield - July 2025 Recap Short-Term Trading Opportunity Alerts - fcp.pa.gov.br | 11/05/2025 |
5 | Ranking Petros Pharmaceuticals Inc. among high performing stocks via tools - Earnings Miss AI Forecast Swing Trade Picks - newser.com | 11/14/2025 |
6 | Ranking Salarius Pharmaceuticals Inc. among high performing stocks via tools - Market Risk Summary Fast Moving Market Watchlists - newser.com | 11/19/2025 |
7 | Adial Pharmaceuticals enters 2.86M inducement at 0.31 exercise price - Stock Titan | 11/26/2025 |
About Via Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Via or other stocks. Alpha measures the amount that position in Via Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2011 | 2024 | 2025 (projected) | Interest Debt Per Share | 17.04 | 0.86 | 0.99 | 0.94 | Revenue Per Share | 2.78 | 0.0168 | 0.0193 | 0.0183 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Via Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Via Pharmaceuticals' short interest history, or implied volatility extrapolated from Via Pharmaceuticals options trading.
Build Portfolio with Via Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Via Stock Analysis
When running Via Pharmaceuticals' price analysis, check to measure Via Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Via Pharmaceuticals is operating at the current time. Most of Via Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Via Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Via Pharmaceuticals' price. Additionally, you may evaluate how the addition of Via Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.